Petros Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Petros Pharma using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
PTPI | Petros Pharmaceuticals | -$1.69 | — | — | — | $1.39M | — | — | — | 05/14/2025 | Get Alert |
PTPI | Petros Pharmaceuticals | -$2.17 | — | -$1.16 | — | $364.25K | — | $725.40K | — | 03/31/2025 | Get Alert |
PTPI | Petros Pharmaceuticals | -$2.85 | -$0.29 | -$0.53 | -82.76% | $1.68M | $1.34M | $1.58M | 17.61% | 11/13/2024 | Get Alert |
PTPI | Petros Pharmaceuticals | -$1.20 | -$0.77 | -$0.37 | 51.95% | $1.99M | $1.40M | $1.42M | 1.50% | 08/14/2024 | Get Alert |
PTPI | Petros Pharmaceuticals | -$6.60 | -$1.44 | -$1.69 | -17.36% | $2.52M | $1.45M | $1.39M | -4.21% | 05/15/2024 | Get Alert |
PTPI | Petros Pharmaceuticals | -$2.03 | -$1.11 | -$2.17 | -95.50% | $798.10K | $1.55M | $364.25K | -76.50% | 04/01/2024 | Get Alert |
PTPI | Petros Pharmaceuticals | -$6.70 | — | -$2.31 | — | -$1.46M | — | $1.68M | — | 11/15/2023 | Get Alert |
PTPI | Petros Pharmaceuticals | -$0.90 | — | -$1.20 | — | $4.19M | — | $1.99M | — | 08/14/2023 | Get Alert |
PTPI | Petros Pharmaceuticals | -$0.10 | — | -$6.60 | — | $2.46M | — | $2.52M | — | 05/15/2023 | Get Alert |
PTPI | Petros Pharmaceuticals | -$7.50 | — | -$2.03 | — | -$867.16K | — | $798.10K | — | 03/31/2023 | Get Alert |
PTPI | Petros Pharmaceuticals | -$0.17 | — | -$6.70 | — | $2.15M | — | -$1.46M | — | 11/15/2022 | Get Alert |
PTPI | Petros Pharmaceuticals | -$2.20 | — | -$0.90 | — | $2.46M | — | $4.19M | — | 08/15/2022 | Get Alert |
PTPI | Petros Pharmaceuticals | $3.10 | — | -$0.10 | — | $4.10M | — | $2.46M | — | 05/16/2022 | Get Alert |
PTPI | Petros Pharmaceuticals | — | — | -$7.50 | — | — | — | -$867.16K | — | 04/01/2022 | Get Alert |
PTPI | Petros Pharmaceuticals | -$9.60 | — | -$1.70 | — | $3.46M | — | $2.15M | — | 11/15/2021 | Get Alert |
PTPI | Petros Pharmaceuticals | — | — | -$2.20 | — | — | — | $2.46M | — | 08/16/2021 | Get Alert |
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-13 | $-0.53 | $-0.29 | -82.8 % |
Q2 | 2024-08-14 | $-0.37 | $-0.77 | 51.9 % |
Q1 | 2024-05-15 | $-1.69 | $-1.44 | -17.4 % |
Q4 | 2024-04-01 | $-2.17 | $-1.11 | -95.5 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-13 | $1.58M | $1.34M | 17.6 % |
Q2 | 2024-08-14 | $1.42M | $1.40M | 1.50 % |
Q1 | 2024-05-15 | $1.39M | $1.45M | -4.21 % |
Q4 | 2024-04-01 | $364.25K | $1.55M | -76.5 % |
Petros Pharma (PTPI) is scheduled to report earnings on May 14, 2025. The last reported earnings were for reported on March 31, 2025 for Q4.
The Actual EPS was $-1.16, which missed the estimate of $0.00.
The Actual Revenue was $725.4K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.